What Are Peptides? A Clinical and Research Guide

Peptides have moved from a specialist biochemistry topic to something clinicians, researchers and patients all ask about — largely because several of the most significant drug classes of the last decade are peptide-based.

What a peptide actually is

A peptide is a short chain of amino acids joined by peptide bonds. The only real difference between a peptide and a protein is length: chains of roughly 2–50 amino acids are generally called peptides, and longer chains are called proteins. There is no hard biochemical boundary — the distinction is one of convention.

That short length matters practically. Peptides are small enough to be synthesised reliably in a laboratory and characterised precisely, which is why they became attractive as drug molecules.

Peptides in established medicine

Several peptide-based drugs are entirely mainstream:

• Insulin — the original peptide therapeutic, in clinical use since the 1920s.
• GLP-1 receptor agonists — used in type 2 diabetes and, more recently, in weight management.
• Vasopressin and desmopressin — used in diabetes insipidus and some bleeding disorders.
• Octreotide — a somatostatin analogue used in acromegaly and certain neuroendocrine tumours.
• Calcitonin and teriparatide — used in bone metabolism disorders.

These are approved medicines, prescribed and dispensed through normal regulatory channels.

Why peptides are attractive as drugs

Peptides bind their targets with high specificity, which tends to mean fewer off-target effects than small-molecule drugs. They are also broken down into amino acids, so they generally do not accumulate in tissue.

The trade-offs are real. Most peptides are digested if swallowed, which is why the majority are injected. They are cleared quickly, so dosing can be frequent unless the molecule is engineered for a longer half-life. And they are more expensive to manufacture than conventional small-molecule drugs.

Research peptides

Beyond approved medicines, a much larger number of peptides exist as research compounds — synthesised and supplied for laboratory investigation, receptor studies, assay development and preclinical work.

Research-grade material is supplied for laboratory use only. It has not been through the clinical trial process that establishes safety and efficacy in humans, and it is not manufactured to pharmaceutical standards. Suppliers in this space, such as Buy Peptides, serve laboratory and research customers rather than clinical ones.

The regulatory position in Singapore

This is the part that matters most for anyone reading from Singapore.

Health products in Singapore are regulated by the Health Sciences Authority (HSA) under the Health Products Act. Therapeutic products must be registered before they can be supplied for human use, and prescription-only medicines require a prescription from a registered practitioner.

• Importing unregistered therapeutic products for personal use is restricted, and the allowances are narrow.
• Material labelled "for research use only" is not approved for human administration, and that labelling is not a technicality.
• Supplying unregistered therapeutic products is an offence.

If you are considering a peptide-based treatment, that conversation belongs with a registered medical practitioner, using a registered product obtained through legitimate channels.

Handling and storage in a laboratory setting

Peptides are generally supplied lyophilised (freeze-dried) because they are more stable in that form. Typical laboratory practice is cold storage of the lyophilised powder, reconstitution immediately before use, and avoiding repeated freeze–thaw cycles, which degrade the peptide.

Singapore's humidity is a genuine practical problem here — lyophilised material is hygroscopic, and vials should be brought to room temperature before opening so condensation does not draw moisture into the powder.

Laboratory weighing equipment for this kind of work is in laboratory scales, and general laboratory and clinic supplies across our catalogue.

This article is general information about a class of molecules. It is not medical advice, not a recommendation to use any peptide, and not a guide to self-administration. Peptide therapies for human use in Singapore should be discussed with a registered medical practitioner and obtained through HSA-regulated channels.